RecruitingNCT07329673

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms.

Sponsor

Qbtech AB

Enrollment

300 participants

Start Date

Jan 1, 2026

Study Type

OBSERVATIONAL

Conditions

Bi-Polar Disorder Autism Spectrum Disorder (ASD)Major Depression Disorders Separation Anxiety Disorder Social Anxiety Disorder Generalized Anxiety Disorder (GAD)

Summary

The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.

Eligibility

Min Age: 6 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Digital software application for cognitive performance and activity measurement (QbMobile, investigational device) for people with autism spectrum disorder (asd), bi-polar disorder, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDigital software application for cognitive performance and activity measurement (QbMobile, investigational device)

Participants will complete two non-invasive, 10-minute digital tests using the QbMobile Investigational Device-one at the clinic and one at home the following day. The tests objectively measure cognitive performance and activity levels and will not influence clinical diagnosis or treatment in this study.